Remove 2028 Remove Patients Remove Physicians
article thumbnail

The continued shame of pharma

World of DTC Marketing

Nationwide, prescription drug spending last year is estimated to be $328 billion among all payers, including private insurance, Medicare Part D, and patients’ out-of-pocket expenses. This would include drugs covered by both Medicare Part B (physician-administered drugs) and Part D (prescription medications).

Pharma 256
article thumbnail

Improving Patient-Physician Interaction with AI-Enhanced Data

PM360

In the rapidly evolving global healthcare landscape, the relationship between patients and healthcare professionals (HCPs) remains crucial for effective treatment and care delivery. highlighting the urgent need for improving patient outcomes in the country. highlighting the urgent need for improving patient outcomes in the country.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

An app can never replace a doctor

World of DTC Marketing

Together with the growth in wearables—projected to be worth nearly $120 billion by 2028—we are seeing growing democratization of knowledge of one’s own body, with tech enabling consumers to take a more active and regular role in their healthcare. Physicians have not bought into the hype around apps. The Economist.

Doctors 208
article thumbnail

Genetic Counselors Insight: Growing Popularity of At Home Testing

InCrowd

We first asked – What do you think about patients doing at home testing? The primary response from our experts was recommending to: -Speak with Primary Care Physician/Obtain a referral from your PCP. For example, Everlywell, LetsGetChecked, 23andMe etc? Who should look into genetic testing? cancer, cardiac disease, etc).

article thumbnail

CD19 CAR-T agents to boost blood cancer market

European Pharmaceutical Review

The number of blood cancer patients receiving CD19-directed CAR-T therapies is set to boom over the next decade from approximately 3,700 patients in 2021 to nearly 13,500 patients in 2031. This allows for a large total eligible patient population despite capturing less patient share relative to other CD19 CAR-T agents.

article thumbnail

Your Guide to Virtual Reality Reimbursement in the U.S. Healthcare Market

Nixon Gwilt Law

Providers are already integrating Virtual Reality ( VR ) into patient care in a variety of ways. So, how do patients get access to this technology, and how do providers get paid for using it? Reimbursement impacts patient access, business and revenue models, investment potential, and product development.

article thumbnail

Consequences of the First 10 Drugs Selected for Medicare’s Negotiation Program

PM360

This article covers some of the reasons these drugs were chosen, how the process for price negotiation will occur, and the impact for the industry and for patients. Over the next few weeks, manufacturers will submit a range of clinical, marketing, sales, pricing, and patient data, and then meet with CMS to discuss submissions later this fall.